Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the efficacy of early intervention (dosing within 2 hours of onset of the migraine attack) with eletriptan 40mg on mild versus moderate to severe pain intensity of migraine.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| eletriptan | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate pain free response at 2 hours with eletriptan 40mg in mild pain compared to moderate to severe pain intensity of migraine in early intervention. |
| Measure | Description | Time Frame |
|---|---|---|
| To demonstrate the efficacy of early intervention with eletriptan 40mg on mild compared to moderate to severe migraine pain include the following clinical outcomes: pain-free at 0.5, 1, 1.5, 4 and 24 hours; sustained pain-free, migraine recurrence |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Edmonton | Alberta | Canada | |||
| Pfizer Investigational Site |
Not provided
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Chilliwack |
| British Columbia |
| Canada |
| Pfizer Investigational Site | Coquitlam | British Columbia | Canada |
| Pfizer Investigational Site | Langley | British Columbia | Canada |
| Pfizer Investigational Site | North Vancouver | British Columbia | Canada |
| Pfizer Investigational Site | Penticton | British Columbia | Canada |
| Pfizer Investigational Site | Winnipeg | Manitoba | Canada |
| Pfizer Investigational Site | Bathurst | New Brunswick | Canada |
| Pfizer Investigational Site | Moncton | New Brunswick | Canada |
| Pfizer Investigational Site | St. John's | Newfoundland and Labrador | Canada |
| Pfizer Investigational Site | Halifax | Nova Scotia | Canada |
| Pfizer Investigational Site | Truro | Nova Scotia | Canada |
| Pfizer Investigational Site | Bolton | Ontario | Canada |
| Pfizer Investigational Site | Brampton | Ontario | Canada |
| Pfizer Investigational Site | Corunna | Ontario | Canada |
| Pfizer Investigational Site | Fort Erie | Ontario | Canada |
| Pfizer Investigational Site | Hamilton | Ontario | Canada |
| Pfizer Investigational Site | London | Ontario | Canada |
| Pfizer Investigational Site | Markham | Ontario | Canada |
| Pfizer Investigational Site | Mississauga | Ontario | Canada |
| Pfizer Investigational Site | Newmarket | Ontario | Canada |
| Pfizer Investigational Site | Niagara Falls | Ontario | Canada |
| Pfizer Investigational Site | Woodstock | Ontario | Canada |
| Pfizer Investigational Site | Montague | Prince Edward Island | Canada |
| Pfizer Investigational Site | Cowansville | Quebec | Canada |
| Pfizer Investigational Site | Drummondville | Quebec | Canada |
| Pfizer Investigational Site | Granby | Quebec | Canada |
| Pfizer Investigational Site | Montreal | Quebec | Canada |
| Pfizer Investigational Site | Québec | Quebec | Canada |
| Pfizer Investigational Site | Sainte-Julie | Quebec | Canada |
| Pfizer Investigational Site | Sherbrooke | Quebec | Canada |
| Pfizer Investigational Site | Regina | Saskatchewan | Canada |
| Pfizer Investigational Site | Mount Pearl | Canada |
| ID | Term |
|---|---|
| D008881 | Migraine Disorders |
| ID | Term |
|---|---|
| D051270 | Headache Disorders, Primary |
| D020773 | Headache Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C115647 | eletriptan |
Not provided
Not provided
Not provided